Lyndra Therapeutics

Relay Therapeutics is a biotechnology company based in Cambridge, MA, specializing in motion-based drug design. With a team of experts and their innovative Dynamo platform, they integrate various tools to develop groundbreaking therapies for patients. Their scientific approach and pipeline of publications demonstrate their commitment to advancing the field of drug discovery. As a leader in the industry, Relay Therapeutics attracts investors and media attention, while also offering rewarding career opportunities. Their dedication to patient well-being is evident through their engagement in clinical trials and commitment to responsible practices. With a focus on collaboration and business development, Relay Therapeutics is poised to make significant contributions to the healthcare sector.Generated from the website

Aegerion Pharmaceuticals, Inc is a biopharmaceutical company based in Cambridge, MA. Specializing in the development and commercialization of innovative therapies for rare diseases, the company focuses on addressing unmet medical needs in niche patient populations. With a commitment to research and development, Aegerion Pharmaceuticals, Inc strives to improve the lives of individuals living with rare diseases through the advancement of novel treatment options. By collaborating with healthcare professionals and patients, the company aims to make a meaningful impact in the field of rare disease management. Generated from their business information

ChemGenes Corporation, a biotechnology company, recently relocated to a state of the art facility in Wilmington, Massachusetts. We have consistently been a strong partner to researchers engaged in the field of DNA/RNA synthesis for 23 years. By starting out as a supplier of 'Ultra Pure Products' and then also by becoming an active Contract Researcher, ChemGenes Corporation has achieved unparalleled expertise in the field of DNA/RNA synthesis. Thus, all of us at ChemGenes have the opportunity and great pleasure to serve a vast number of scientists in the US and all over the world.ChemGenes' product lines include phosphoramidites for RNA and DNA synthesis, Antisense phosphoramidites, modified bases for DNA, as well as RNA modification. In addition, we produce a variety of modified phosphoramidites for the introduction of chromophores and ligands. The availability of prepacked disposable columns of various pore sizes, loadings, low volume columns, ancillary reagents in configurations suitable for each synthesizer, and DNA purification cartridges is another way ChemGenes meets its customers needs.A large variety of Reagents for the synthesis of DNA/RNA are also available, which include many natural and modified nucleoside bases, tetrazole, 5-thioethyltetrazole, DMT-chloride, DMT protected deoxy and ribo nucleosides, 2'-O-methyl and 2'-O-propargyl nucleosides, silyl protected ribonucleosides, several types of phosphorylating reagents, and many more.